Association between Changes in Total Antioxidant Levels and Clinical Symptom Improvement in Patients with Antipsychotic-Naïve First-Episode Schizophrenia after 3 Months of Risperidone Monotherapy

Schizophrenia (SCZ) is associated with aberrant redox regulation in the early stages of brain development. There is growing evidence that the antioxidant defense system is closely associated with the therapeutic response to antipsychotics in SCZ patients. The aim of this study was to examine the eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Keqiang, Xiu, Meihong, Su, Xiuru, Wu, Fengchun, Zhang, Xiangyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029332/
https://www.ncbi.nlm.nih.gov/pubmed/35453331
http://dx.doi.org/10.3390/antiox11040646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029332/
https://www.ncbi.nlm.nih.gov/pubmed/35453331
http://dx.doi.org/10.3390/antiox11040646

Ejemplares similares